136 related articles for article (PubMed ID: 30646831)
1. KLHL6 is a tumor suppressor gene in diffuse large B-cell lymphoma.
Choi J; Zhou N; Busino L
Cell Cycle; 2019 Feb; 18(3):249-256. PubMed ID: 30646831
[TBL] [Abstract][Full Text] [Related]
2. Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2.
Choi J; Lee K; Ingvarsdottir K; Bonasio R; Saraf A; Florens L; Washburn MP; Tadros S; Green MR; Busino L
Nat Cell Biol; 2018 May; 20(5):586-596. PubMed ID: 29695787
[TBL] [Abstract][Full Text] [Related]
3. PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.
Choi J; Saraf A; Florens L; Washburn MP; Busino L
Cell Cycle; 2018; 17(18):2243-2255. PubMed ID: 30209976
[TBL] [Abstract][Full Text] [Related]
4. Klhl6 Deficiency Impairs Transitional B Cell Survival and Differentiation.
Bertocci B; Lecoeuche D; Sterlin D; Kühn J; Gaillard B; De Smet A; Lembo F; Bole-Feysot C; Cagnard N; Fadeev T; Dahan A; Weill JC; Reynaud CA
J Immunol; 2017 Oct; 199(7):2408-2420. PubMed ID: 28807996
[TBL] [Abstract][Full Text] [Related]
5. Expression, purification, and microscopic characterization of the tumor suppressor KLHL6.
Han L; Chen Z; Sun L
Protein Expr Purif; 2023 Oct; 210():106318. PubMed ID: 37286065
[TBL] [Abstract][Full Text] [Related]
6. CRL3-SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the MyD88/NF-κB signaling.
Jin X; Shi Q; Li Q; Zhou L; Wang J; Jiang L; Zhao X; Feng K; Lin T; Lin Z; Zhuang H; Yang J; Hu C; Zhang L; Shen L; Lu Y; Zhu J; Wang H; Qi H; Meng X; Xi Y; Pan J; Fang S; Tian H; Zhou C; Zhang P; Gao K; Zhao SM; Li Y; Gong Z; Wang C
Leukemia; 2020 May; 34(5):1305-1314. PubMed ID: 31776466
[TBL] [Abstract][Full Text] [Related]
7. Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-cell Lymphoma.
Meriranta L; Sorri S; Huse K; Liu X; Spasevska I; Zafar S; Chowdhury I; Dufva O; Sahlberg E; Tandaric L; Karjalainen-Lindsberg ML; Hyytiainen M; Varjosalo M; Myklebust JH; Leppa S
Blood Cancer Discov; 2024 Apr; ():. PubMed ID: 38630892
[TBL] [Abstract][Full Text] [Related]
8. The BTB-kelch protein KLHL6 is involved in B-lymphocyte antigen receptor signaling and germinal center formation.
Kroll J; Shi X; Caprioli A; Liu HH; Waskow C; Lin KM; Miyazaki T; Rodewald HR; Sato TN
Mol Cell Biol; 2005 Oct; 25(19):8531-40. PubMed ID: 16166635
[TBL] [Abstract][Full Text] [Related]
9. Effect of BCLAF1 on HDAC inhibitor LMK-235-mediated apoptosis of diffuse large B cell lymphoma cells and its mechanism.
Li X; He Z; Cheng B; Fang Q; Ma D; Lu T; Wei D; Kuang X; Tang S; Xiong J; Wang J
Cancer Biol Ther; 2018; 19(9):825-834. PubMed ID: 29969367
[TBL] [Abstract][Full Text] [Related]
10. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.
Yang Y; Kelly P; Shaffer AL; Schmitz R; Yoo HM; Liu X; Huang DW; Webster D; Young RM; Nakagawa M; Ceribelli M; Wright GW; Yang Y; Zhao H; Yu X; Xu W; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza L; Staudt LM
Cancer Cell; 2016 Apr; 29(4):494-507. PubMed ID: 27070702
[TBL] [Abstract][Full Text] [Related]
11. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J
Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312
[TBL] [Abstract][Full Text] [Related]
12. CUL4B regulates autophagy via JNK signaling in diffuse large B-cell lymphoma.
Li Y; Zhou X; Zhang Y; Yang J; Xu Y; Zhao Y; Wang X
Cell Cycle; 2019 Feb; 18(4):379-394. PubMed ID: 30612524
[TBL] [Abstract][Full Text] [Related]
13. The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.
van Keimpema M; Grüneberg LJ; Schilder-Tol EJ; Oud ME; Beuling EA; Hensbergen PJ; de Jong J; Pals ST; Spaargaren M
Haematologica; 2017 Mar; 102(3):573-583. PubMed ID: 27909217
[TBL] [Abstract][Full Text] [Related]
14. Evidence for an oncogenic modifier role for mutant histone acetyltransferases in diffuse large B-cell lymphoma.
Haery L; Mussakhan S; Waxman DJ; Gilmore TD
Leuk Lymphoma; 2016 Nov; 57(11):2661-71. PubMed ID: 27003102
[TBL] [Abstract][Full Text] [Related]
15. RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.
Zhang M; Xu-Monette ZY; Li L; Manyam GC; Visco C; Tzankov A; Wang J; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Pham LV; Young KH
Aging (Albany NY); 2016 Dec; 8(12):3321-3340. PubMed ID: 27941215
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.
Lenz G; Davis RE; Ngo VN; Lam L; George TC; Wright GW; Dave SS; Zhao H; Xu W; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Chan WC; Staudt LM
Science; 2008 Mar; 319(5870):1676-9. PubMed ID: 18323416
[TBL] [Abstract][Full Text] [Related]
17. Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression.
Zhang C; Liu J; Huang G; Zhao Y; Yue X; Wu H; Li J; Zhu J; Shen Z; Haffty BG; Hu W; Feng Z
Genes Dev; 2016 Sep; 30(17):1956-70. PubMed ID: 27664236
[TBL] [Abstract][Full Text] [Related]
18. AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.
Tsai HJ; Shih NY; Kuo SH; Cheng AL; Lin HY; Chen TY; Chang KC; Lin SF; Chang JS; Chen LT
Leuk Lymphoma; 2015; 56(9):2674-82. PubMed ID: 25535814
[TBL] [Abstract][Full Text] [Related]
19. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
[TBL] [Abstract][Full Text] [Related]
20. Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway.
Ramachandiran S; Adon A; Guo X; Wang Y; Wang H; Chen Z; Kowalski J; Sunay UR; Young AN; Brown T; Mar JC; Du Y; Fu H; Mann KP; Natkunam Y; Boise LH; Saavedra HI; Lossos IS; Bernal-Mizrachi L
Int J Cancer; 2015 May; 136(10):2341-51. PubMed ID: 25359525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
